Five‐year risk of cardiovascular events in women with history of pregnancy complicated by fetal growth restriction
OBJECTIVE: To evaluate the association between fetal growth restriction (FGR) and adverse maternal cardiovascular outcomes within 5 years postpartum. METHODS: This was a retrospective study that used a global federated health research network (TriNetX) in which diagnoses are coded using the International Classification of Diseases, tenth revision, Clinical Modification system (ICD-10-CM). Nulliparous women aged ≥ 18 years, without prior cardiovascular disease and with a singleton pregnancy delivered between April 2006 and December 2020, were categorized by the presence or absence of FGR (ICD-10-CM: O36.5). 1:1 propensity-score matching (PSM) was applied using two models: Model 1, matching for pre-existing cardiovascular risk factors; and Model 2, matching for both pre-existing and other pregnancy-related cardiovascular risk factors. Cox regression proportional hazard models were used to estimate hazard ratios (HRs) with 95% CI for a maternal composite cardiovascular outcome including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke within 5 years postpartum, and for each of these components individually. RESULTS: After PSM, 84 863 women per group were analyzed in Model 1 and 84 861 per group in Model 2. FGR was associated with an increased risk of the composite cardiovascular outcome (Model 1: HR, 1.33 (95% CI, 1.16-1.52); Model 2: HR, 1.31 (95% CI, 1.15-1.50)), as well as with an increased risk of each of the components of the composite outcome individually: heart failure (Model 1: HR, 1.29 (95% CI, 1.08-1.54); Model 2: HR, 1.30 (95% CI, 1.09-1.56)), acute myocardial infarction (Model 1: HR, 1.55 (95% CI, 1.16-2.08); Model 2: HR, 1.53 (95% CI, 1.15-2.05)) and cerebral infarction/ischemic stroke (Model 1: HR, 1.38 (95% CI, 1.09-1.74); Model 2: HR, 1.33 (95% CI, 1.06-1.68)) within 5 years postpartum. CONCLUSIONS: FGR in a first pregnancy is associated with increased maternal composite cardiovascular risk, including heart failure, acute myocardial infarction and cerebral infarction/ischemic stroke, within 5 years postpartum. These findings suggest that FGR may be a marker of early cardiovascular vulnerability. However, residual confounding, particularly by unmeasured timing or severity of pre-eclampsia, cannot be excluded. Also, FGR was identified using coding constructs based on electronic health records, which may include overlap with broader 'suspected poor growth' phenotypes such as small-for-gestational age, hence potentially diluting the observed associations. Earlier risk assessment and preventive strategies may help to reduce the risk of long-term morbidity and mortality in this population. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Authors
- Keerthana Anand (ORCID: https://orcid.org/0000-0001-8768-2435)
- Tommaso Bucci (ORCID: https://orcid.org/0000-0003-2895-6234)
- Abi Merriel (ORCID: https://orcid.org/0000-0003-0352-2106)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Maria Sudell (ORCID: https://orcid.org/0000-0002-7919-4981)
Institutions
- Medical University of Białystok (PL)
- University of Liverpool (GB)
- University of Perugia (IT)
- Liverpool Heart and Chest Hospital (GB)
- Liverpool Women's Hospital (GB)
- Liverpool John Moores University (GB)
- Aalborg University (DK)
Publication Details
- Journal
- Ultrasound in Obstetrics and Gynecology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1002/uog.70387
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care